Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in CATALYST PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 279,281 shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $6.5M as of 2025-Q4. The position was increased (++0.7% shares). CPRX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$6.5M
Current Shares
279,281
Total Value Change
+$2.6M
Total Shares Change
+28,161
Other major holders of CPRX: BNP PARIBAS FINANCIAL MARKETS, CAPITAL FUND MANAGEMENT S.A., BlackRock, Inc.
Increased |
| 279,281 |
+0.7% |
| $6.5M |
| 0.0% |
| $23.29 |
27 |
| 2025-Q3 | Decreased | 277,301 | -52.6% | $5.5M | 0.0% | $19.55 | 0 |
| 2025-Q2 | Increased | 585,671 | +11.3% | $12.7M | 0.0% | $21.78 | 31 |
| 2025-Q1 | Increased | 526,297 | +99.4% | $12.8M | 0.0% | $24.69 | 45 |
| 2024-Q4 | Increased | 263,905 | +11.7% | $5.5M | 0.0% | $21.07 | 30 |
| 2024-Q3 | Decreased | 236,222 | -5.9% | $4.7M | 0.0% | $19.56 | 0 |
| 2024-Q2 | Increased | 251,120 | +117.0% | $3.9M | 0.0% | $15.49 | 43 |